Product
Technology
Resources
Company
LoginStart Free Trial

A Leading Bayesian Therapeutic
Drug Monitoring Software for

Model-Informed Precision Dosing (MIPD)

The Most Accurate and Comprehensive Vancomycin AUC Dosing Tool*
SOC2, ISO/IEC 27001:2013, CE-Marked, HIPAA and GDPR Compliant
Book A DemoContact Us
*Validated by independent research — Turner et al 2018; 38(12):1174-1183 ACCP
Independently endorsed by GlobalRPH as Vancomycin AUC Dosing Calculator of choice
Inputs to the PrecisePK system, such as patient characteristics, lab re
TRUSTED BY
PrecisePK is trusted by UCSF Benioff Children's Hospitals, Sharp Hospitals, Stony Brook University Hospital, Sparrow, Bronson, University of Maryland Shore Regional Health, UCSD Health, Dignity Health, Sonoma Valley Hospital, ProHealth Care, Tri-City Medical Center, the VA, and many others
TRUSTED BY
Learn More About Our Industry Leading
Vancomycin AUC 
Bayesian Dosing
Fully compliant with 2020 ASHP/ISDA Vancomycin Guidelines.
Our Product
Learn More About Our Industry Leading
Vancomycin AUC 
Bayesian Dosing
Fully compliant with 2020 ASHP/ISDA Vancomycin Guidelines.
Our Product

Learn More About Our Industry Leading

Vancomycin AUC 
Bayesian Dosing

Fully compliant with 2020 ASHP/IDSA Vancomycin Guidelines.
Our Product
PrecisePK is the leading TDM software which fully complies with the 2020 Vancomycin Dosing Guidelines and recommended by many professionals for its intuitive user interface and easy of use.

NEW!

Real-time Monitoring and Data-driven Analytics for Acute Kidney Injury Management

PrecisePK TDM software provides real-time analytics to predict and manage Acute Kidney Injury from Vancomycin dosing

PrecisePK Is
Now Available In

English
Español
中文
ไทย
한국어

Testimonials from Our Customers

100+
ACTIVE
PARTNERSHIPS
10+
COUNTRIES WORLDWIDE

PrecisePK has been in the industry for many years, formerly known as TDMS, and hence stands out as a top therapeutic drug monitoring platform due to its history. The new version is amazing visually and user-friendly too, requiring minimal training.

The unique features of this platform that I find especially helpful for patient care are flexibility in selecting neonatal, pediatric and adult models to ensure you select the best Bayesian prior for your patient population; and adjustment for special populations, including obese, critically-ill status and post-cardiac surgery.

Dr. Jennifer Le
Pharm. D,., MAS, FIDSA, FCCP, FCSHP, BCPS-ID
Professor of Clinical Pharmacy
Director of Experiential Education in
Los Angeles-Orange County
" Easy to use, works as well as the more complicated pharmacokinetic software programs. "
Bill Murray, Pharm. D
" Vancomycin pharmacokinetic predictions come quite close to measured trough levels. "
Kevin Callahan, Pharm.D
" I personally found PrecisePK very helpful. Not only is it easy to navigate... I like how there are multiple vancomycin regimen options to work with, in addition to the ability to compare trough versus AUC, and individual versus population dosing. I like how you can dose on not only vancomycin but on other medications that need pharmacokinetic monitoring. "
Aileen Nguyen, Pharmacy Resident
" The program has helped my research become vastly more efficient due to the ease of inputting patient information and determining dosing recommendations… PrecisePK has been the most reliable dosing tool that I’ve used for daily vancomycin dosing and other research pursuits. "
Lauren Dea, Pharm.D
" Easy to use, works as well as the more complicated pharmacokinetic software programs. "
Bill Murray, Pharm. D
" Vancomycin pharmacokinetic predictions come quite close to measured trough levels. "
Kevin Callahan, Pharm.D
" I personally found PrecisePK very helpful. Not only is it easy to navigate... I like how there are multiple vancomycin regimen options to work with, in addition to the ability to compare trough versus AUC, and individual versus population dosing. I like how you can dose on not only vancomycin but on other medications that need pharmacokinetic monitoring. "
Aileen Nguyen, Pharmacy Resident
" The program has helped my research become vastly more efficient due to the ease of inputting patient information and determining dosing recommendations… PrecisePK has been the most reliable dosing tool that I’ve used for daily vancomycin dosing and other research pursuits. "
Lauren Dea, Pharm.D
" Easy to use, works as well as the more complicated pharmacokinetic software programs. "
Bill Murray, Pharm. D
" Vancomycin pharmacokinetic predictions come quite close to measured trough levels. "
Kevin Callahan, Pharm.D
" The program has helped my research become vastly more efficient due to the ease of inputting patient information and determining dosing recommendations… PrecisePK has been the most reliable dosing tool that I’ve used for daily vancomycin dosing and other research pursuits. "
Lauren Dea, Pharm.D

State of the Art Bayesian-Guided
Busulfan & Vancomycin AUC Targeting

With Bayesian-guided dosing software, complex calculation can be done easily, yielding more accurate results while only requiring a single blood level draw. In contrast, traditional calculation of AUC involves tedious manual calculation and two blood level draws. This increases cost, time taken and typically results in underestimation, decreasing dose efficacy.

Bayesian-guided dosing uses Bayes’ theorem with population PK parameters as Bayesian prior and a patient’s observed serum concentrations to calculate the Bayesian posterior PK parameters. Using this to derive an individualized PK profile, PrecisePK can largely reduce toxicity and improve dosing efficacy with potentially lower costs.

Reduced Nephrotoxicity
Individualized Dosing
Single Blood Draw
Increased Savings
Increased Savings
Single Blood Draw
Individualized Dosing Recommendation
Reduced Nephrotoxicity

What You Can Do With PrecisePK

By providing recommendations and visualizations based on an individualized approach rather than a general approach, patients can reach their therapeutic targets more efficiently. As PrecisePK gathers more data from your patient records, it will automatically adjust its models to help you dose quickly, safely, and accurately.
Obtain precise and individualized dosage recommendations
Analyze results with interactive graphs
Compare outcomes with population-based models
Integrate with your EHR for optimal workflow
Obtain precise and individualized dosage recommendations
Analyze results with interactive graphs
Compare outcomes with population-based models
Obtain precise and individualized dosage recommendations
Analyze results with interactive graphs
Compare outcomes with population-based models
Integrate with your EHR for optimal workflow
Learn more about our solution
Learn more about our solution

Maximize Your Return on Investment.
Improve Clinical Efficiency.

Length of hospital stay reduced up to
10 days
using therapeutic drug monitoring system
van Lent-Evers NA et al. Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis. 1999;21(1):63‐73.
Vancomycin AUC24 Bayesian software saves around
$60,305
per 500 beds per annum
Paul E Sabourenkov et al. AUC24 Vancomycin Bayesian-Based Dosing: Increasing Therapeutic Target Attainment with Decreased TDM Cost. October 2019.
Incidence of nephrotoxicity can be reduced by
10.5%
using therapeutic drug monitoring system
van Lent-Evers NA et al. Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis. 1999;21(1):63‐73.
Therapeutic drug monitoring projects annual savings of
$37,000
by influencing changes in process variables
Schumacher GE, Barr JT. Economic and outcome issues for therapeutic drug monitoring in medicine. 1998.

Therapeutic drug monitoring projects annual savings of

$37,000
by influencing changes
in process variables

Vancomycin AUC24 Bayesian software saves around

$60,305
per 500 beds per annum

Length of hospital stay reduced up to

10 days
using therapeutic drug
monitoring system

Incidence of nephrotoxicity can be reduced by

10.5%
using therapeutic drug
monitoring system

Why PrecisePK?

Comparing our solution to other providers
Others

All-inclusive drug bundles and associated population models

Yes

Most accurate and least biased Bayesian prediction for vancomycin AUC

Yes

Flexible customer optimization on software features

Yes

Available in 5 different languages (English, Spanish, Chinese, Korean & Thai)

Yes

Capability to integrate with multiple EHR systems

Yes

Free

Starter (20% off)

Business

ACCOUNTS

Clones

Up to 20 clones per month

Categories

Business, Technology

User Limit

1 User

DESIGN INTERACTIONS

Lottie Animation

3 months

Design Interactions

3 months

DESIGN INTERACTIONS

Clones

Categories

-

ACCOUNTS

Clones

Up to 20 clones per month

Categories

Business, Technology

User Limit

1 User

DESIGN INTERACTIONS

Lottie Animation

3 months

Design Interactions

3 months

DESIGN INTERACTIONS

Clones

Categories

-

ACCOUNTS

Clones

Up to 20 clones per month

Categories

Business, Technology

User Limit

1 User

DESIGN INTERACTIONS

Lottie Animation

3 months

Design Interactions

3 months

DESIGN INTERACTIONS

Clones

Categories

-

Our Latest Articles & Updates

Discover insights on drugs and dosing guidelines.

Kern Medical Chooses PrecisePK to Provide Bayesian Precision Dosing Solutions

SAN DIEGO, May 25, 2023-- Today, PrecisePK welcomes Kern Medical as its latest institution to implement innovations in precision dosing for vancomycin and other antibiotics using the Bayesian AUC-based method. "PrecisePK has helped to standardize and improve our vancomycin dosing workflow, and is especially suited to our diverse patient population since special patient factors, renal function calculations, and other components can be customized or factored into Bayesian prior selection," says Dr. Fang.

PrecisePk Pharm. D. Team

May 25, 2023

Scandinavia's Largest Hospital Becomes Second Institution in Norway to Adopt PrecisePK's Bayesian Dosing Software

SAN DIEGO, May 3, 2023– Today, PrecisePK announces that it will begin partnering with Oslo University Hospital (OUS) in Norway. PrecisePK is delighted to welcome OUS on board as its second Norwegian health institution, following the University Hospital of North Norway (UNN).

PrecisePk Pharm. D. Team

May 3, 2023

See All Blogs

PrecisePK has been in the industry for many years, formerly known as TDMS, and hence stands out as a top therapeutic drug monitoring platform due to its history. The new version is amazing visually and user-friendly too, requiring minimal training.

The unique features of this platform that I find especially helpful for patient care are flexibility in selecting neonatal, pediatric and adult models to ensure you select the best Bayesian prior for your patient population; and adjustment for special populations, including obese, critically-ill status and post-cardiac surgery.

Dr. Jennifer Le
PharmD, MAS, FIDSA, FCCP, FCSHP, BCPS-ID
Professor of Clinical Pharmacy
Director of Experiential Education in Los Angeles- Orange County Skaggs School of Pharmacy and Pharmaceutical Sciences
100+
ACTIVE
PARTNERSHIPS
10+
COUNTRIES WORLDWIDE
Easy to use, works as well as the more complicated pharmacokinetic software programs.
Bill Murray, Pharm. D
Vancomycin pharmacokinetic predictions come quite close to measured trough levels.
Kevin Callahan, Pharm.D
The program has helped my research become vastly more efficient due to the ease of inputting patient information and determining dosing recommendations… PrecisePK has been the most reliable dosing tool that I’ve used for daily vancomycin dosing and other research pursuits.
Lauren Dea, Pharm.D

Try PrecisePK Precision Dosing Software Free for 60 days

Optimize Your Clinical Experience with PrecisePK.
Book A DemoContact Us

Request User Manual

We'll contact you with a download link for PrecisePK user manual.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This website uses cookies to ensure you get the best experience on our website. Learn more here.
Accept
CompanyLegal Contact UsCareersPreciseRX
ProductTechnologyAKI PredictionBook A DemoLogin
Resources
ArticlesFAQsChangelog
Copyright © Healthware, Inc. 2023